Systemic lupus erythematosus: analysis of the clinical case
https://doi.org/10.65249/1027-7218-2026-1-65-73
Abstract
The article is devoted to the problem of polymorbidity of systemic lupus erythematosus (SLE). A clinical case of SLE with a chronic course, which at a certain stage of the disease occurred with peripartal cardiomyopathy and acute kidney injury, is described in detail. The presence of SLE in the patient made it difficult to diagnose concomitant pathology timely, since the development of peripartal cardiomyopathy was initially regarded as lupus carditis, as well as acute hemodynamic and medicinal kidney injury as lupus nephritis.
About the Author
N. Soroka
Минский научно-практический центр хирургии, трансплантологии и гематологии
Belarus
Belarus
References
1. Siegel C.H., Sammaritano L.R. Systemic lupus erythematosus. JAMA. 2024; 331(17): 1480–1491.
2. Somers E.C., Marder W., Cagnoli P., et al. Population-based incidence and prevalence of systemic lupus erythematosus. Arthritis Rheumatol. 2014; 66(2): 369–378.
3. Yurkovich M., Vostretsova K., Chen W.J., Avina-Zubieta J.A. Overall and cause-specific mortality in patients with systemic lupus erythematosus. Arthritis Care Res. 2014; 66: 608–616.
4. Dai X., Fan Y., Zhao X. Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics. Signal Transduct Target Ther. 2025; 10. doi: 10.1038/s41392-025-02168-0.
5. Goli R., Li J., Brandimarto J., et al. Genetic and phenotypic landscape of peripartum cardiomyopathy. Circulation. 2021; 143(19): 1852–1862.
6. Davis N.B., Arany Z., McNamara D.M., et al. Peripartum cardiomyopathy. J Am Coll Cardiol. 2020; 75(2): 207–221.
7. Kadiwar S., Smith J.J., Ledot S., et al. Were pregnant women more affected by COVID-19 in the second wave of the pandemic? Lancet. 2021; 397: 1539–1540.
8. Bultmann B.D., Klingel K., Nabauer M., et al. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol. 2005; 193: 363–365.
9. Regitz-Zagrosek V., Roos-Hesselink J.W., Bauersachs J., et al. ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018; 39(34): 3165–3241.
10. McNamara D.M., Elkayam U., Alharethi R., et al. IPAC investigators. Clinical outcomes for peripartum cardiomyopathy in North America. J Am Coll Cardiol. 2015; 66: 905–914.
11. Irizarry O.C., Levine L.D., Lewey J., et al. Comparison of clinical characteristics and outcomes of peripartum cardiomyopathy between African American and non-African American women. JAMA Cardiol. 2017; 2: 1256–1260.
12. Amos A.M., Jaber W.A., Russell S.D. Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J. 2006; 152: 509–513.
Review
For citations:
Soroka N. Systemic lupus erythematosus: analysis of the clinical case. Healthcare. 2026;(1):65-73. (In Russ.) https://doi.org/10.65249/1027-7218-2026-1-65-73
Views:
1096
JATS XML
Email this article 